Key points are not available for this paper at this time.
The present study demonstrated that APOL3 promotes ferroptosis and immunotherapy in colorectal cancer cells. The present work provides us with a novel target to overcome drug resistance to ferroptosis and immunotherapy.
Lv et al. (Sun,) studied this question.